Doxorubicin (generic), Adriamycin, Doxil News

You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes included in this annual report.

CytRx Corporation , a biopharmaceutical research and development company specializing in oncology, today reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs.

The formation of resveratrol stabilized gold nanoparticles was confirmed by the observation of the surface plasmon resonance band at 537 nm."

ABSTRACT: Great advances have been made in the arena of cancer drug therapy. A number of modalities, such as targeted therapies, have emerged that have drastically changed the clinical landscape of cancer-related drug therapy.

The company manufactures and markets pharmaceutical products for healthcare market.

Nanohybrid liposomes including doxorubicin and Magnevist, a contrast agent for magnetic resonance imaging, with 120-130 nm mean diameter and a narrow size distribution were developed."

A dextran-based nano carrier system with aldehyde functionalities capable of forming an acid labile linkage with the chemotherapy drug doxorubicin was developed.."